Clinical trials rebound after COVID-19 setbacks, and early treatment leads to significant reduction in anal cancer risk among people with HIV.

by Thomas Celona

A new AACR report tracks progress in addressing cancer health disparities and identifies work that still needs to be done.

by Eric Fitzsimmons

Changes to what medical debt is included in credit reports could give patients more time to resolve outstanding bills.

by Karon Warren

Patients who lose weight through bariatric surgery have a lower cancer risk, and a HER2-targeted therapy gets striking results in HER2-low breast cancer patients.

by Kevin McLaughlin

Contrast dye shortage delays scans for cancer, and more public assistance linked to higher survival rates for Black cancer patients.

by Eric Fitzsimmons

A blood test could help determine who benefits from checkpoint inhibitors in lung cancer, and the FDA approves a drug combination for certain patients with acute myeloid leukemia.

by Marci A. Landsmann

Esophageal cancer increases in the middle-aged, and adolescent and young adult leukemia survivors face continued mortality risk after treatment ends.

by Eric Fitzsimmons

New studies shine a light on the effects of a cancer diagnosis on mental health and suicide risk.

by Pamela Rafalow Grossman

First child to receive CAR T-cell therapy celebrates 10 years cancer-free, and authorization denials delay treatment for patients with Medicare Advantage.

by Marci A. Landsmann

Adolescents and young adult cancer survivors at higher risk for dying from a new cancer diagnosis, and FDA grants full approval to Enhertu for metastatic HER2-postive breast cancer.

by Eric Fitzsimmons